Web Results

Andrulis v. Celgene: District Court Dismisses Undivided Direct ...

patentlaw.jmbm.com/2014/04/andrulis-v-celgene-district-co.html

Apr 21, 2014 ... Plaintiff Andrulis Pharmaceuticals Corp. ("Andrulis") filed a patent infringement action against Celgene Corporation ("Celgene") alleging direct, ...

Celgene Accused Of Infringing Cancer Treatment Patent - Law360

www.law360.com/articles/477863/celgene-accused-of-infringing-cancer-treatment-patent

Oct 3, 2013 ... Andrulis Pharmaceuticals Corp. accused rival drugmaker Celgene Corp. of inducing the ... The case is Andrulis Pharmaceuticals Corp. v.

District Court Finds Enhanced Patent Indefiniteness - PharmaPatents

www.pharmapatentsblog.com/2015/08/04/district-court-finds-enhanced-patent-indefiniteness/

Aug 4, 2015 ... I don't usually write about district court decisions, but the patent indefiniteness ruling in Andrulis Pharmaceuticals Corp. v. Celgene Corp.

View Complaint - RPX Search

search.rpxcorp.com/litigation_documents/10301225

Oct 2, 2013 ... For its Complaint, Andrulis Pharmaceuticals Corp., by and through its attorneys, ... (“Celgene”) is a Delaware corporation with its principal.

An Update On Appellate Review Of Indefiniteness - Covington ...

www.cov.com/-/media/files/corporate/publications/2016/05/an_update_on_appellate_review_of_indefiniteness.pdf

May 12, 2016 ... ... and/or some combination of the two.”[10]. Andrulis Pharmaceuticals Corp. v. Celgene Corp. is another example of this type of indefiniteness.

Upcoming Oral Arguments | US Court of Appeals for the Federal ...

www.cafc.uscourts.gov/argument/upcoming-oral-arguments

15-1962, DCT, Andrulis Pharmaceuticals Corp. v. Celgene Corporation, [argued]. 15-3148, MSPB, Kermes v. DHS, [argued]. 16-1098, PATO, Netac Technology ...

Patent US7230012 - Pharmaceutical compositions and dosage ...

www.google.com/patents/US7230012

Jun 12, 2007 ... Pharmaceutical compositions and single unit dosage forms of thalidomide and ... such as, but not limited to, leprosy, chronic graft-vs-host disease, rheumatoid arthritis, sarcoidosis, ... Original Assignee, Celgene Corporation ...... US5405855, Dec 23, 1993, Apr 11, 1995, Andrulis Pharmaceuticals Corp.

Patent Docs: Court Report - Patentdocs.org

www.patentdocs.org/2013/10/court.html

Oct 6, 2013 ... Andrulis Pharmaceuticals Corp. v. Celgene Corp. 1:13-cv-01644; filed October 2, 2013 in the District Court of Delaware. Infringement of U.S. ...

Posts in Motion to Strike/Preclude: Delaware Patent Litigation Report

www.morrisjames.com/blogs-Delaware-Patent-Litigation-Report,category,motion-to-strikepreclude

Apr 13, 2016 ... St. Clair Intellectual Property Consultants, Inc. v. Toshiba .... Celgene Corporation , et al. v. Fresenius Kabi .... Andrulis Pharmaceuticals Corp. v.

1-14-cv-00028-LPS-59-PRIMARY DOCUMENT - Patently-O

patentlyo.com/media/2015/10/1-14-cv-00028-LPS-59-PRIMARY-DOCUMENT.pdf

at 1) The Supreme Court set forth in World-Wide Volkswagen Corp. v. Woodson, 444 ..... this way since the Act's passage in 2011. See Andrulis Pharm. Corp. v. Celgene Corp., C.A. No. 13-1644-RGA ..... See Fuisz Pharma LLC v. Theranos ...

More Info

Celgene Gets Claims Trimmed From Andrulis Drug Patent Suit ...

www.law360.com

Apr 11, 2014 ... The case is Andrulis Pharmaceuticals Corp. v. Celgene Corp., case number 1:13- cv-01644, in the U.S. District Court for the District of Delaware.

Andrulis Pharmaceuticals Corp. v. Celgene Corp., No. 1 ... - Justia Law

law.justia.com

Jun 26, 2015 ... Andrulis Pharmaceuticals Corp. v. Celgene Corp., No. 1:2013cv01644 - Document 149 (D. Del. 2015) case opinion from the District of ...

Judge Andrews dismisses direct infringement claims in part, finds ...

www.delawareiplaw.com

Apr 17, 2014 ... In Andrulis Pharmaceuticals Corp. v. Celgene Corporation, C.A. No. 13-1644- RGA (D. Del. Apr. 10, 2014), Judge Richard G. Andrews ...